Use of strontium for bovine oocyte activation
-
Add time:08/28/2019 Source:sciencedirect.com
Strontium efficiently activates mouse oocytes, however, there is limited information on its use in cattle. Thus, the objective of this study was to establish a suitable protocol for activating bovine oocyte with strontium. For pronuclear development, the absence of calcium and magnesium in the activation medium (TALP) with 10 and 50 mM strontium (34.4 and 53.1%, respectively) was superior to the complete TALP (6.5 and 19.4%, respectively). In all activation media, better results were observed with 25 and 50 mM strontium (21.9–53.1 and 19.4–53.1%, respectively). Incubation for 4 h promoted similar results in all strontium concentrations. However, strontium at 15, 20, and 25 mM for 6 and 8 h (40.7, 46.7, and 48.3%, and 29.3, 48.3, and 40.7%, respectively) were superior to control (15.5 and 10%, respectively). After in vitro maturation for 26 h, strontium (S; 20 mM in Ca2+- and Mg2+-free TALP for 6 h), ionomycin + strontium (IS), and strontium + ionomycin (SI) (60, 63.3, and 65%, respectively) were similar in pronuclear development and superior to ionomycin (I; 5 μM for 5 min; 36.7%). In treatments S and I, only 1 PN zygotes were observed. In treatment S, most of them had 1 and 2 PB (35.7 and 60.7%, respectively), and in treatment I, 0, 1, and 2 PB (14.3, 57.1, and 28.6%, respectively). Most of the zygotes in treatment IS and SI were 1 PN 2 PB (77.4 and 61.6%, respectively). The number of oocytes with clusters of cortical granules was similar in all treated groups (11–29%). Cortical granule exocytosis in treatment IS (68%) was similar to S (54%) and superior to I, SI, and control (27, 45, and 5.0%, respectively). Cleavage and blastocyst rates were similar for S, I, IS, and SI treatments (61.7–76.7, and 8.3–13.3%, respectively) and the same was observed for ICM, TE, and total cell number, and ICM/total cell ratio (22–25, 64–69, and 86–95, and 0.26–0.27). In conclusion, strontium may be efficiently applied for bovine oocyte activation at 20 mM in Ca2+- and Mg2+-free TALP medium for 6 h.
We also recommend Trading Suppliers and Manufacturers of Strontium azide (cas 19465-89-5). Pls Click Website Link as below: cas 19465-89-5 suppliers
Prev:Chapter 11 Decomposition of azides
Next:Manganese-calcium/strontium heterometallic compounds and their relevance for the oxygen-evolving center of photosystem II) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Manganese-calcium/strontium heterometallic compounds and their relevance for the oxygen-evolving center of photosystem II08/29/2019
- Chapter 11 Decomposition of azides08/27/2019
- Short communicationPreclinical evaluation of strontium-containing bioactive bone cement08/26/2019
- Osteogenic, anti-osteoclastogenic and immunomodulatory properties of a strontium-releasing hybrid scaffold for bone repair08/25/2019
- Strontium effects on root dentin tubule occlusion and nanomechanical properties08/24/2019
- The thermal stability of γ-irradiated Strontium azide (cas 19465-89-5)08/23/2019
- The coirradiated decomposition of barium and Strontium azide (cas 19465-89-5)s08/22/2019
- The photolysis of barium and Strontium azide (cas 19465-89-5)s08/21/2019
- Electronic structure and optical properties of crystalline Strontium azide (cas 19465-89-5) and barium azide by ab initio pseudopotential plane-wave calculations08/20/2019
-
Health and Chemical more >


